Latest News

U.S. has new dominant COVID variant called EG.5


 

COVID-19 hospitalizations continue their steady summer march upward, and now a new variant has perched atop the list of the most prevalent forms of the virus.

Called “Eris” among avid COVID trackers, the strain EG.5 now accounts for 17% of all U.S. COVID infections, according to the latest Centers for Disease Control and Prevention estimates. That’s up from 12% the week prior.

EG.5 has been rising worldwide, just weeks after the World Health Organization added the strain to its official monitoring list. In the United Kingdom, it now accounts for 1 in 10 COVID cases, The Independent reported.

EG.5 is a descendant of the XBB strains that have dominated tracking lists in recent months. It has the same makeup as XBB.1.9.2 but carries an extra spike mutation, according to a summary published by the Center for Infectious Disease Research and Policy at the University of Minnesota. The spike protein is the part of the virus that allows it to enter human cells. But there’s no indication so far that EG.5 is more contagious or severe than other recent variants, according to the CIDRAP summary and a recent podcast from the American Medical Association. The CDC said that current vaccines protect against the variant.

U.S. hospitals saw a 12% increase in COVID admissions during the week ending on July 22, with 8,047 people being admitted because of the virus, up from an all-time low of 6,306 the week of June 24. In 17 states, the past-week increase in hospitalizations was 20% or greater. In Minnesota, the rate jumped by 50%, and in West Virginia, it jumped by 63%. Meanwhile, deaths reached their lowest weekly rate ever for the week of data ending July 29, with just 176 deaths reported by the CDC.

A version of this article first appeared on WebMD.com.

Recommended Reading

Sewer data says Ohio person has had COVID for 2 years
MDedge Infectious Disease
Millions who had COVID-19 still don’t have sense of smell, taste
MDedge Infectious Disease
Latest data: COVID vaccine safety, protection, and breakthrough infections in inflammatory, autoimmune diseases
MDedge Infectious Disease
FDA panel backs new COVID booster focusing only on variants
MDedge Infectious Disease
Postacute effects of COVID on par with those of sepsis, flu
MDedge Infectious Disease
Long COVID ‘brain fog’ confounds doctors, but new research offers hope
MDedge Infectious Disease
Nearly one in five in U.S. still hadn’t gotten COVID by end of 2022
MDedge Infectious Disease
Deer populations pose COVID risk to humans: Study
MDedge Infectious Disease
Long COVID and vaccines: Separating facts from falsehoods
MDedge Infectious Disease
New air monitor can detect COVID virus in 5 minutes
MDedge Infectious Disease